GAM
BNTX icon

Generali Asset Management’s BioNTech BNTX Stock Holding History

Generali Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651 Hold
7
– – ﹤0.01% 525
2026
Q1 		$622 Hold
7
– – ﹤0.01% 483
2025
Q4 		$666 Hold
7
– – ﹤0.01% 482
2025
Q3 		$690 Hold
7
– – ﹤0.01% 498
2025
Q2 		$745 Hold
7
– – ﹤0.01% 497
2025
Q1 		$637 Hold
7
– – ﹤0.01% 493
2024
Q4 		$798 Buy
+7
New +$799 ﹤0.01% 478

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Generali Asset Management's BNTX Position: Q2 2026 in Review

Generali Asset Management held its BioNTech (BNTX) position steady in Q2 2026 at 7 shares worth $651. The position accounts for ﹤0.01% of the portfolio, ranked #525.

Generali Asset Management first reported a position in BNTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $798 in Q4 2024. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Generali Asset Management held 7 shares of BioNTech worth $651 as of Q2 2026.
  • Generali Asset Management left its BioNTech share count unchanged in Q2 2026.
  • BioNTech made up ﹤0.01% of Generali Asset Management's portfolio in Q2 2026, its #525 holding.
  • Generali Asset Management first reported a position in BioNTech in Q4 2024 and has held it in 7 quarters since.
  • Generali Asset Management's BioNTech position peaked at $798 in Q4 2024.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.